BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 28745797)

  • 1. Expressions and significances of TTF-1 and PTEN in early endometrial cancer.
    Zhang HM; Fan TT; Li W; Li XX
    Eur Rev Med Pharmacol Sci; 2017 Jul; 21(3 Suppl):20-26. PubMed ID: 28745797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Value of circulating tumor cells positive for thyroid transcription factor-1 (TTF-1) to predict recurrence and survival rates for endometrial carcinoma.
    Zhang Y; Qu X; Qu PP
    J BUON; 2016; 21(6):1491-1495. PubMed ID: 28039713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PTEN negative correlates with miR-181a in tumour tissues of non-obese endometrial cancer patients.
    Geletina NS; Kobelev VS; Babayants EV; Feng L; Pustylnyak VO; Gulyaeva LF
    Gene; 2018 May; 655():20-24. PubMed ID: 29477866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Role of miR-155 in invasion and metastasis of lung adenocarcinoma A549 cells].
    Cheng TL; Hu CP; Li M; Gu QH; An J
    Zhonghua Zhong Liu Za Zhi; 2016 Feb; 38(2):86-92. PubMed ID: 26899325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Preliminary investigation of the expression and functions of insulin receptor isoforms in endometrial carcinoma].
    Zhang G; Li XP; Wang JL; Wei LH
    Zhonghua Fu Chan Ke Za Zhi; 2012 Nov; 47(11):839-45. PubMed ID: 23302125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of survivin, PTEN and p27 in normal, hyperplastic, and carcinomatous endometrium.
    Erkanli S; Kayaselcuk F; Kuscu E; Bagis T; Bolat F; Haberal A; Demirhan B
    Int J Gynecol Cancer; 2006; 16(3):1412-8. PubMed ID: 16803539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppressed expression of insulin-like growth factor binding protein-1 mRNA in the endometrium: a molecular mechanism associating endometrial cancer with its risk factors.
    Rutanen EM; Nyman T; Lehtovirta P; Ammälä M; Pekonen F
    Int J Cancer; 1994 Nov; 59(3):307-12. PubMed ID: 7523316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of PTEN immunoreactivity in endometrial hyperplasia and adenocarcinoma.
    Tantbirojn P; Triratanachat S; Trivijitsilp P; Niruthisard S
    J Med Assoc Thai; 2008 Aug; 91(8):1161-5. PubMed ID: 18788685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of thyroid transcription factor-1 in normal endometrium is associated with risk of endometrial cancer development.
    Sullivan PS; Maresh EL; Seligson DB; Habeeb O; Wadehra M; Goodglick L; Dorigo O
    Mod Pathol; 2012 Aug; 25(8):1140-8. PubMed ID: 22460811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of phosphatase and tensin homologue in imprint smears of endometrial carcinoma.
    Kosmas K; Mitropoulou G; Provatas I; Stamoulas M; Marouga A
    Cytopathology; 2018 Dec; 29(6):558-564. PubMed ID: 30007089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation between NDRG1 and PTEN expression in endometrial carcinoma.
    Chen J; Li S; Yang Z; Lu G; Hu H
    Cancer Sci; 2008 Apr; 99(4):706-10. PubMed ID: 18377423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation between PTEN expression and PI3K/Akt signal pathway in endometrial carcinoma.
    Gao Q; Ye F; Xia X; Xing H; Lu Y; Zhou J; Ma D
    J Huazhong Univ Sci Technolog Med Sci; 2009 Feb; 29(1):59-63. PubMed ID: 19224164
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of the insulin-like growth factor I receptor and activation of the AKT pathway in hyperplastic endometrium.
    McCampbell AS; Broaddus RR; Loose DS; Davies PJ
    Clin Cancer Res; 2006 Nov; 12(21):6373-8. PubMed ID: 17085648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Expression and clinical significance of Beclin1 and PTEN in endometrial carcinoma].
    Zhao JH; Wan XY; Xie X; Zhou CY; Wu QY
    Ai Zheng; 2006 Jun; 25(6):753-7. PubMed ID: 16764775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential expression of microRNAs miR-21, miR-31, miR-203, miR-125a-5p and miR-125b and proteins PTEN and p63 in verrucous carcinoma of the head and neck.
    Odar K; Boštjančič E; Gale N; Glavač D; Zidar N
    Histopathology; 2012 Aug; 61(2):257-65. PubMed ID: 22690848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemical evaluation of PTEN protein in patients with endometrial intraepithelial neoplasia compared to endometrial adenocarcinoma and proliferative phase endometrium.
    Cirpan T; Terek MC; Mgoyi L; Zekioglu O; Iscan O; Ozsaran A
    Eur J Gynaecol Oncol; 2006; 27(4):389-92. PubMed ID: 17009632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Expression and relationship of Ezh2, Runx3 and caspase-3 in endometrial adenocarcinoma].
    Guo ZL; Chen K; Wang XQ; Hu W
    Zhonghua Bing Li Xue Za Zhi; 2011 Jun; 40(6):387-91. PubMed ID: 21914347
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-106b promotes pituitary tumor cell proliferation and invasion through PI3K/AKT signaling pathway by targeting PTEN.
    Zhou K; Zhang T; Fan Y; Serick ; Du G; Wu P; Geng D
    Tumour Biol; 2016 Oct; 37(10):13469-13477. PubMed ID: 27465551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [PTEN coding product: a marker for tumorigenesis and progression of endometrial carcinoma].
    Gao QL; Ye F; Li J; Xing H; Lu YP; Ma D
    Ai Zheng; 2003 Jun; 22(6):640-4. PubMed ID: 12948417
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Highly increased maspin expression corresponds with up-regulation of miR-21 in endometrial cancer: a preliminary report.
    Torres A; Torres K; Paszkowski T; Radej S; Staśkiewicz GJ; Ceccaroni M; Pesci A; Maciejewski R
    Int J Gynecol Cancer; 2011 Jan; 21(1):8-14. PubMed ID: 21330826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.